Dr. Daniel Ermann, MD
Claim this profileStudies Neonatal Pneumonia
Studies Lymphoma
1 reported clinical trial
2 drugs studied
Clinical Trials Daniel Ermann, MD is currently running
More about Daniel Ermann, MD
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Daniel Ermann, MD has experience with
- Pneumococcal 13-valent Conjugate Vaccine
- Pneumococcal Polyvalent Vaccine
Breakdown of trials Daniel Ermann, MD has run
Neonatal Pneumonia
Lymphoma
T-Lymphoblastic Leukemia/Lymphoma
Lymphoid Leukemia
Mycoplasma Pneumonia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Ermann, MD specialize in?
Daniel Ermann, MD focuses on Neonatal Pneumonia and Lymphoma. In particular, much of their work with Neonatal Pneumonia has involved treating patients, or patients who are undergoing treatment.
Is Daniel Ermann, MD currently recruiting for clinical trials?
Yes, Daniel Ermann, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Daniel Ermann, MD has studied deeply?
Yes, Daniel Ermann, MD has studied treatments such as Pneumococcal 13-valent Conjugate Vaccine, Pneumococcal Polyvalent Vaccine.
What is the best way to schedule an appointment with Daniel Ermann, MD?
Apply for one of the trials that Daniel Ermann, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.